# Enliven Therapeutics, Inc.: Form 8-K/A, filed May 29, 2024

- Company: [Enliven Therapeutics, Inc.](/companies/elvn.md) (CIK 1672619)
- Form: 8-K/A
- Filed: 2024-05-29
- Accepted by EDGAR: May 29, 2024, 16:06 ET
- Period: 2024-04-08
- Accession: 0001193125-24-149141
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1672619/000119312524149141/d816859d8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1672619/000119312524149141/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1672619/000119312524149141/d816859d8ka.htm

Filed May 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-149141. Last ingested by Listed: Nov 5, 2026, 17:49 ET. No prices; not investment advice.